Aurora Cannabis (ACB) EBIT Margin (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly EBIT Margin of 3.51% for Q1 2026, up 2532.0% year-on-year from 0.13% in Q1 2025, and down 79.26% on a QoQ basis from 16.92% in Q4 2025.
Aurora Cannabis (ACB) EBIT Margin (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported EBIT Margin for 10 consecutive years, with 3.51% the latest figure, recorded in Q1 2026.
- Quarterly EBIT Margin rose 2532.0% year-over-year to 3.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.17% (up 464.0% YoY) and the FY2026 annual result came in at 14.55%, down 1627.0% from the prior year.
- EBIT Margin eased to 3.51% in Q1 2026 per ACB's latest filing, from 16.92% in the prior quarter.
- Over the last five years, EBIT Margin for ACB reached as high as 41.79% in Q4 2024 and fell as low as 1043.86% in Q2 2023.
- A 5-year average of 94.82% and a median of 2.64% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2023 — EBIT Margin sank 92397 bps — and 2024, when it surged 104350 bps.
- Year by year, EBIT Margin stood at 109.42% in 2022, then surged by 75 bps to 27.33% in 2023, then surged by 253 bps to 41.79% in 2024, then tumbled by 60 bps to 16.92% in 2025, then sank by 79 bps to 3.51% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 3.51%, 16.92%, and 4.34% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 3.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.51% |
| Dec 31, 2025 | 16.92% |
| Sep 30, 2025 | 4.34% |
| Jun 30, 2025 | -1.54% |
| Mar 31, 2025 | -21.81% |
| Dec 31, 2024 | 41.79% |
| Sep 30, 2024 | -1.36% |
| Jun 30, 2024 | -0.36% |
| Mar 31, 2024 | -3.35% |
| Dec 31, 2023 | -27.33% |
| Sep 30, 2023 | -1.93% |
| Jun 30, 2023 | -1,043.86% |
| Dec 31, 2022 | -109.42% |
| Sep 30, 2022 | -109.31% |
| Jun 30, 2022 | -119.89% |
| Mar 31, 2022 | -143.52% |
| Dec 31, 2021 | -92.09% |
| Sep 30, 2021 | -65.51% |
| Jun 30, 2021 | 26.75% |
| Mar 31, 2021 | -259.16% |